Clinical Trial: Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386003) titled 'Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD' on April 18.

Brief Summary: This is an open-label trial evaluating feasibility, tolerability, safety and efficacy of psilocybin assisted cognitive processing therapy for chronic Posttraumatic Stress Disorder (PTSD).

Study Type: Interventional

Condition: * Post Traumatic Stress Disorder

* PTSD

* Chronic PTSD

Intervention: Drug: Psilocybin

Participants will receive a single dose of psilocybin 25mg combined with 12 sessions of massed CPT, and 2 psychotherapy sessions related to psilocybin over 7 days.

Recruitment Status: Not Yet Recruiting

Published by HT Digit...